Exclusive: Most patients using weight-loss drugs like Wegovy stop within a year, data show

By Reuters
| July 12, 2023

Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk's Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...